FDA
label_change
· 2013-02-16
FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Fresenius Kabi USA, LLC)
Summary
The FDA approved a supplemental application for Levothyroxine Sodium (levothyroxine sodium anhydrous) from Fresenius Kabi USA, LLC.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for LEVOTHYROXINE SODIUM (LEVOTHYROXINE SODIUM ANHYDROUS)